mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.024 |
0.7 |
mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.7 |
mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
0.025 |
0.7 |
mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.7 |
mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
HG-6-64-1 |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.7 |